Published in AIDS Weekly, October 28th, 1996
BioChem Pharma discovered Epivir/3TC (lamivudine) for the treatment of HIV/AIDS. Dr. Francesco Bellini, BioChem Pharma, welcomed the opportunity to have the patent issue settled through the U.S. legal system. "The federal courts provide us with the appropriate forum to finally put to rest Emory University's baseless claims to 3TC. Their action does a grave disservice to the late Dr. Belleau and all of the brilliant and dedicated scientists, who pioneered this discovery, which is currently...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.